Literature DB >> 35984555

Update on the Practical Role of Echocardiography in Selection, Implantation, and Management of Patients Requiring Left Ventricular Assist Device Therapy.

Aashish Katapadi1, Matt Umland1, Bijoy K Khandheria2,3.   

Abstract

PURPOSE OF REVIEW: Echocardiography is a valuable tool for management of patients with a left ventricular assist device (LVAD). We present an updated review on the practical applications of the role of echocardiography for pre- and postoperative evaluation of patients selected. RECENT
FINDINGS: The LVAD is a temporary or permanent option for patients with advanced heart failure who are unresponsive to other therapy. Use of the device has its own risks, and implantation remains a complex procedure. Transthoracic and transesophageal echocardiography are useful tools for patient evaluation and monitoring both peri- and postoperatively, as we previously presented. Assessment of left and right ventricular function, complications such as thrombus formation or intracardiac shunting, and valvular disease are all important in this assessment. This also aids in predicting postoperative complications. Placement of the device is confirmed intraoperatively, and subsequent ramp studies are used to determine optimal device settings. Right ventricular (RV) failure is the most common postoperative complication and preoperative evaluation of its function is crucial. Studies suggest that tricuspid annular plane systolic excursion, RV fractional area change, and RV global longitudinal strain are strong predictors of RV failure; LV ejection fraction, size, and end-diastolic diameter are also important markers. Aortic regurgitation and mitral stenosis must always be corrected prior to LVAD placement. However, direct visualization before and after implantation, especially to rule out potential contraindications such as thrombi, cannot be overemphasized. Ramp studies remain an integral part of device optimization and may result in greater myocardial recovery than previously realized.
© 2022. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.

Entities:  

Keywords:  Echocardiography; Heart failure; LVAD; Left ventricle; Right ventricle

Year:  2022        PMID: 35984555     DOI: 10.1007/s11886-022-01771-9

Source DB:  PubMed          Journal:  Curr Cardiol Rep        ISSN: 1523-3782            Impact factor:   3.955


  51 in total

1.  Long-term use of a left ventricular assist device for end-stage heart failure.

Authors:  E A Rose; A C Gelijns; A J Moskowitz; D F Heitjan; L W Stevenson; W Dembitsky; J W Long; D D Ascheim; A R Tierney; R G Levitan; J T Watson; P Meier; N S Ronan; P A Shapiro; R M Lazar; L W Miller; L Gupta; O H Frazier; P Desvigne-Nickens; M C Oz; V L Poirier
Journal:  N Engl J Med       Date:  2001-11-15       Impact factor: 91.245

2.  Echocardiography in the Management of Patients with Left Ventricular Assist Devices: Recommendations from the American Society of Echocardiography.

Authors:  Raymond F Stainback; Jerry D Estep; Deborah A Agler; Emma J Birks; Merri Bremer; Judy Hung; James N Kirkpatrick; Joseph G Rogers; Nishant R Shah
Journal:  J Am Soc Echocardiogr       Date:  2015-08       Impact factor: 5.251

Review 3.  Basic and advanced echocardiography in advanced heart failure: an overview.

Authors:  Maria Concetta Pastore; Giulia Elena Mandoli; Hatem Soliman Aboumarie; Ciro Santoro; Francesco Bandera; Antonello D'Andrea; Giovanni Benfari; Roberta Esposito; Vincenzo Evola; Regina Sorrentino; Paolo Cameli; Serafina Valente; Sergio Mondillo; Maurizio Galderisi; Matteo Cameli
Journal:  Heart Fail Rev       Date:  2020-11       Impact factor: 4.214

4.  Advancing the Science of Myocardial Recovery With Mechanical Circulatory Support: A Working Group of the National, Heart, Lung and Blood Institute.

Authors:  Stavros G Drakos; Francis D Pagani; Martha S Lundberg; J Timothy Baldwin
Journal:  J Card Fail       Date:  2017-04-19       Impact factor: 5.712

Review 5.  Predicting High-Risk Patients and High-Risk Outcomes in Heart Failure.

Authors:  Ramsey M Wehbe; Sadiya S Khan; Sanjiv J Shah; Faraz S Ahmad
Journal:  Heart Fail Clin       Date:  2020-06-29       Impact factor: 3.179

6.  Risk Assessment and Comparative Effectiveness of Left Ventricular Assist Device and Medical Management in Ambulatory Heart Failure Patients: The ROADMAP Study 2-Year Results.

Authors:  Randall C Starling; Jerry D Estep; Douglas A Horstmanshof; Carmelo A Milano; Josef Stehlik; Keyur B Shah; Brian A Bruckner; Sangjin Lee; James W Long; Craig H Selzman; Vigneshwar Kasirajan; Donald C Haas; Andrew J Boyle; Joyce Chuang; David J Farrar; Joseph G Rogers
Journal:  JACC Heart Fail       Date:  2017-04-05       Impact factor: 12.035

Review 7.  The practical role of echocardiography in selection, implantation, and management of patients requiring LVAD therapy.

Authors:  Maria Chiara Todaro; Bijoy K Khandheria; Timothy E Paterick; Matt M Umland; Vinay Thohan
Journal:  Curr Cardiol Rep       Date:  2014-04       Impact factor: 2.931

8.  LVAD decommissioning for myocardial recovery: Long-term ventricular remodeling and adverse events.

Authors:  Eleanor F Gerhard; Lu Wang; Ramesh Singh; Stephan Schueler; Leonard D Genovese; Andrew Woods; Daniel Tang; Nicola Robinson Smith; Mitchell A Psotka; Sian Tovey; Shashank S Desai; Djordje G Jakovljevic; Guy A MacGowan; Palak Shah
Journal:  J Heart Lung Transplant       Date:  2021-08-11       Impact factor: 10.247

9.  Left Ventricular Assist Device as a Bridge to Recovery for Patients With Advanced Heart Failure.

Authors:  Djordje G Jakovljevic; Magdi H Yacoub; Stephan Schueler; Guy A MacGowan; Lazar Velicki; Petar M Seferovic; Sandeep Hothi; Bing-Hsiean Tzeng; David A Brodie; Emma Birks; Lip-Bun Tan
Journal:  J Am Coll Cardiol       Date:  2017-04-18       Impact factor: 24.094

10.  Transhepatic echocardiography: a novel approach for imaging in left ventricle assist device patients with difficult acoustic windows.

Authors:  Mihai Strachinaru; Daniel J Bowen; Alina Constatinescu; Olivier C Manintveld; Jasper J Brugts; Marcel L Geleijnse; Kadir Caliskan
Journal:  Eur Heart J Cardiovasc Imaging       Date:  2020-05-01       Impact factor: 6.875

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.